Perrigo's Next Private Label First Lands With Second Thoughts On Outlook

The launch of a private label version 24HR OTC heartburn treatment comes with Perrigo in need of another high-selling product to boost revenues in its core business, OTC private label. But analysts call for Perrigo to do more to grow in new markets.

Perrigo Co. PLC is optimistic that its newly launched private label version of Nexium 24HR OTC heartburn treatment will provide a needed boost to its core business of OTC private label products. It's both the first-to-market OTC generic version of the product and builds on much higher brand sales than other previous private label launches of proton pump inhibitors.

Esomeprazole magnesium 20 mg delayed-release capsules, indicated to treat frequent heartburn, is now available to US retailers, Perrigo said on...